Health Law Daily CMS will award $50 million to assist states with substance use disorder treatment and recovery
News
Wednesday, June 26, 2019

CMS will award $50 million to assist states with substance use disorder treatment and recovery

By Elena Eyber, J.D.

CMS will award 18-month planning grants to at least 10 state Medicaid agencies, totaling $50 million.

On June 25, 2019, CMS announced a Notice of Funding Opportunity that provides state Medicaid agencies with information to apply for planning grants that will aid in the treatment and recovery of substance use disorders (SUDs), including opioid use disorder (OUD).

The planning grants are intended to increase the capacity of Medicaid providers to deliver SUD treatment and recovery services through an ongoing assessment of the SUD treatment needs of the state; recruitment, training, and technical assistance for Medicaid providers that offer SUD treatment and recovery services; and improved reimbursement for and expansion of the number or treatment capacity of Medicaid providers.

To apply, state Medicaid agencies are required to submit an 18-month proposal by August 9, 2019, to increase the capacity of Medicaid providers throughout the state and quickly deliver SUD treatment and recovery services within local communities. CMS will review the applications and select at least 10 proposals, with awards totaling $50 million.

The application for planning grants is the first step CMS is taking in implementing section 1003 of the Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-27). Enacted on October 24, 2018, the SUPPORT for Patients and Communities Act addresses multiple aspects of the epidemic including treatment, prevention, recovery and enforcement (see Trump signs wide-reaching opioid bill, October 24, 2018). Section 1003 authorizes CMS to conduct a 54-month demonstration project to increase substance use provider capacity, beginning with this 18-month planning phase. Upon completion of the planning phase, up to five states will be selected to carry out a subsequent 36-month demonstration.

MainStory: TopStory CMSNews ControlledNews CoverageNews DrugBiologicNews HealthReformNews MedicaidNews PartANews PartBNews PrescriptionDrugNews QualityNews TherapyNews

Back to Top

Interested in submitting an article?

Submit your information to us today!

Learn More
Health Law Daily

Health Law Daily: Breaking legal news at your fingertips

Sign up today for your free trial to this daily reporting service created by attorneys, for attorneys. Stay up to date on health legal matters with same-day coverage of breaking news, court decisions, legislation, and regulatory activity with easy access through email or mobile app.

Free Trial Learn More